REBCEVAH
Live / Applied — Third extension granted (statement of use) (as of 18 Mar 2026)
What this means for you
Not registered yet, but its 10 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98351114
- Mark type
- Stylized text
- Filed
- 10 Jan 2024
- Published for opposition
- 27 Aug 2024
- Attorney of record
- Yana Gorbach
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; Pharmaceutical preparations for the treatment of sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 19 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Mar 2026 — SOU EXTENSION 3 GRANTED
- 18 Mar 2026 — SOU EXTENSION 3 FILED
- 18 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 30 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 30 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 26 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Aug 2025 — SOU EXTENSION 2 GRANTED
- 25 Aug 2025 — SOU EXTENSION 2 FILED
- 25 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Mar 2025 — SOU EXTENSION 1 GRANTED
- 19 Mar 2025 — SOU EXTENSION 1 FILED